Omidria Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use
May 22, 2015 at 07:01 AM EDT
Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule ...